Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Recommended Measures for Cholera Surveillance and Rapid Surveillance Information Dissemination for Latin America and the Caribbean

Case definitions. Two categories should be used in case definitions in areas with epidemic cholera: clinical and laboratory-confirmed. A clinical case should be defined as acute, watery diarrhea in a person aged greater than or equal to 5 years; a laboratory-confirmed case, as culture-confirmed Vibrio cholerae O1 infection in a person with diarrhea.

Report forms. Lengthy surveillance forms should not be used. Basic data (e.g., age, sex, address, date of onset or treatment, hospitalization, and outcome) can be collected using short forms and kept for analysis at the local level.

Laboratory confirmation of cases. Cultures should be performed for clinical cholera cases in a cholera-threatened area. After cholera has become established in an area, stool cultures should be performed at a reduced frequency (e.g., 10 cultures per month) to confirm the continuing presence of V. cholerae O1 and to monitor antimicrobial resistance.

Surveillance during an evolving epidemic. In areas threatened by cholera, acute dehydrating diarrhea in persons aged greater than or equal to 5 years should be investigated and cultured. When small numbers of cases are being confirmed, only laboratory-confirmed cases should be reported. When the number of laboratory-confirmed cases increases, the clinical case definition should be used for reporting, and culturing should be used only on a limited basis to confirm the continuing presence of cholera. As the number of cholera cases decreases, the definition for clinical cases should be used for at least 1 year to detect seasonal recurrences of the epidemic. To determine routes of cholera transmission and the potential for prevention, case-control investigations should be conducted at outbreak sites.

Analysis and communication of surveillance data. Surveillance data (e.g., numbers of cases, hospitalizations, and deaths) should be transmitted weekly to the central level and analyzed in a timely manner. Summary reports should be disseminated regularly to all components of and levels within the surveillance system and to the Pan American Health Organization.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version ( and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #